Provided by Tiger Fintech (Singapore) Pte. Ltd.

Avadel Pharmaceuticals plc

9.29
-0.1500-1.59%
Volume:680.03K
Turnover:6.33M
Market Cap:900.21M
PE:-33.90
High:9.70
Open:9.44
Low:9.26
Close:9.44
Loading ...

BRIEF-Avadel announces grant of inducement awards under Nasdaq listing rule

Reuters
·
17 Jun

Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
17 Jun

Avadel Pharmaceuticals Gets Orphan Drug Designation for Lumryz to Treat Idiopathic Hypersomnia

MT Newswires Live
·
05 Jun

BRIEF-Avadel Pharmaceuticals Receives Orphan Drug Designation From FDA For Lumryz

Reuters
·
05 Jun

Avadel Pharmaceuticals Receives Orphan Drug Designation From FDA for Lumryz™ (Sodium Oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

THOMSON REUTERS
·
05 Jun

Avadel Pharmaceuticals Files Initial Statement of Beneficial Ownership for Susan Rodriguez, Chief Operating Officer

Reuters
·
14 May

Avadel Pharmaceuticals Names Chief Operating Officer

MT Newswires Live
·
14 May

BRIEF-Avadel Pharmaceuticals Expands Leadership Team With Appointment Of Susan Rodriguez As Chief Operating Officer

Reuters
·
14 May

Avadel Pharmaceuticals Expands Leadership Team With Appointment of Susan Rodriguez as Chief Operating Officer

THOMSON REUTERS
·
14 May

Press Release: Avadel Pharmaceuticals Expands Leadership Team with Appointment of Susan Rodriguez as Chief Operating Officer

Dow Jones
·
14 May

Avadel Pharmaceuticals Price Target Maintained With a $19.00/Share by Needham

Dow Jones
·
08 May

Stock Track | Avadel Pharmaceuticals Soars 12.85% on Strong Q1 Results and Raised 2025 Guidance

Stock Track
·
07 May

Avadel Pharmaceuticals PLC reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
07 May

Stock Track | Avadel Pharmaceuticals Soars 10.76% Pre-Market on Strong Q1 Results and Raised Guidance

Stock Track
·
07 May

Avadel Pharmaceuticals Q1 EPS $(0.05) Misses $(0.01) Estimate, Sales $52.51M Miss $58.75M Estimate

Benzinga
·
07 May

BRIEF-Avadel Pharmaceuticals Q1 EPS USD -0.05

Reuters
·
07 May

Avadel Pharmaceuticals Plc - Outlook 2025 Expects to Generate $255 - $265 Mln in Net Product Revenue

THOMSON REUTERS
·
07 May

Avadel Pharmaceuticals Q1 Operating Income USD -3.001 Million

THOMSON REUTERS
·
07 May

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
07 May

BRIEF-Avadel Pharmaceuticals Announces Favorable Ruling In Appeal Of Delaware Court Injunction

Reuters
·
07 May